-
1
-
-
58349099832
-
Functional models of Parkinson's disease: a valuable tool in the development of novel therapies
-
1 Jenner, P., Functional models of Parkinson's disease: a valuable tool in the development of novel therapies. Ann. Neurol. 64:Suppl. 2 (2008), S16–S29.
-
(2008)
Ann. Neurol.
, vol.64
, pp. S16-S29
-
-
Jenner, P.1
-
2
-
-
0032568534
-
alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies
-
2 Spillantini, M.G., et al. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 95 (1998), 6469–6473.
-
(1998)
Proc. Natl. Acad. Sci. U.S.A.
, vol.95
, pp. 6469-6473
-
-
Spillantini, M.G.1
-
3
-
-
84866702836
-
α-Synuclein in Parkinson's disease
-
3 Stefanis, L., α-Synuclein in Parkinson's disease. Cold Spring Harb. Perspect. Med., 2, 2012, a009399.
-
(2012)
Cold Spring Harb. Perspect. Med.
, vol.2
, pp. a009399
-
-
Stefanis, L.1
-
4
-
-
51549090572
-
Discovery and characterization of three novel synuclein genes in zebrafish
-
4 Sun, Z., Gitler, A.D., Discovery and characterization of three novel synuclein genes in zebrafish. Dev. Dyn. 237 (2008), 2490–2495.
-
(2008)
Dev. Dyn.
, vol.237
, pp. 2490-2495
-
-
Sun, Z.1
Gitler, A.D.2
-
5
-
-
79959819262
-
High-content behavioral analysis of Caenorhabditis elegans in precise spatiotemporal chemical environments
-
5 Albrecht, D.R., Bargmann, C.I., High-content behavioral analysis of Caenorhabditis elegans in precise spatiotemporal chemical environments. Nat. Methods 8 (2011), 599–605.
-
(2011)
Nat. Methods
, vol.8
, pp. 599-605
-
-
Albrecht, D.R.1
Bargmann, C.I.2
-
6
-
-
84868217672
-
Multiparameter behavioral profiling reveals distinct thermal response regimes in Caenorhabditis elegans
-
6 Ghosh, R., et al. Multiparameter behavioral profiling reveals distinct thermal response regimes in Caenorhabditis elegans. BMC Bio., 10, 2012, 85.
-
(2012)
BMC Bio.
, vol.10
, pp. 85
-
-
Ghosh, R.1
-
7
-
-
41949097891
-
C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging
-
7 van Ham, T.J., et al. C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet., 4, 2008, e1000027.
-
(2008)
PLoS Genet.
, vol.4
, pp. e1000027
-
-
van Ham, T.J.1
-
8
-
-
33746533924
-
Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models
-
8 Cooper, A.A., et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313 (2006), 324–328.
-
(2006)
Science
, vol.313
, pp. 324-328
-
-
Cooper, A.A.1
-
9
-
-
84946924520
-
A systematic RNAi screen of neuroprotective genes identifies novel modulators of alpha-synuclein-associated effects in transgenic Caenorhabditis elegans
-
Published online November 14, 2015
-
9 Jadiya, P., et al. A systematic RNAi screen of neuroprotective genes identifies novel modulators of alpha-synuclein-associated effects in transgenic Caenorhabditis elegans. Mol. Neurobiol., 2015 Published online November 14, 2015 http://dx.doi.org/10.1007/s12035-015-9517-3.
-
(2015)
Mol. Neurobiol.
-
-
Jadiya, P.1
-
10
-
-
84888255506
-
Neuron-specific feeding RNAi in C. elegans and its use in a screen for essential genes required for GABA neuron function
-
10 Firnhaber, C., Hammarlund, M., Neuron-specific feeding RNAi in C. elegans and its use in a screen for essential genes required for GABA neuron function. PLoS Genet., 9, 2013, e1003921.
-
(2013)
PLoS Genet.
, vol.9
, pp. e1003921
-
-
Firnhaber, C.1
Hammarlund, M.2
-
11
-
-
84888041171
-
Yeast reveal a “druggable” Rsp5/Nedd4 network that ameliorates alpha-synuclein toxicity in neurons
-
11 Tardiff, D.F., et al. Yeast reveal a “druggable” Rsp5/Nedd4 network that ameliorates alpha-synuclein toxicity in neurons. Science 342 (2013), 979–983.
-
(2013)
Science
, vol.342
, pp. 979-983
-
-
Tardiff, D.F.1
-
12
-
-
84907190544
-
Phosphatidylethanolamine deficiency disrupts alpha-synuclein homeostasis in yeast and worm models of Parkinson disease
-
12 Wang, S., et al. Phosphatidylethanolamine deficiency disrupts alpha-synuclein homeostasis in yeast and worm models of Parkinson disease. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), E3976–E3985.
-
(2014)
Proc. Natl. Acad. Sci. U.S.A.
, vol.111
, pp. E3976-E3985
-
-
Wang, S.1
-
13
-
-
84920740324
-
Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on alpha-synuclein
-
13 Dhungel, N., et al. Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on alpha-synuclein. Neuron 85 (2015), 76–87.
-
(2015)
Neuron
, vol.85
, pp. 76-87
-
-
Dhungel, N.1
-
14
-
-
0034704752
-
A Drosophila model of Parkinson's disease
-
14 Feany, M.B., Bender, W.W., A Drosophila model of Parkinson's disease. Nature 404 (2000), 394–398.
-
(2000)
Nature
, vol.404
, pp. 394-398
-
-
Feany, M.B.1
Bender, W.W.2
-
15
-
-
0036468432
-
Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease
-
15 Auluck, P.K., et al. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295 (2002), 865–868.
-
(2002)
Science
, vol.295
, pp. 865-868
-
-
Auluck, P.K.1
-
16
-
-
84922431034
-
Rab11 modulates alpha-synuclein-mediated defects in synaptic transmission and behaviour
-
16 Breda, C., et al. Rab11 modulates alpha-synuclein-mediated defects in synaptic transmission and behaviour. Hum. Mol. Genet. 24 (2015), 1077–1091.
-
(2015)
Hum. Mol. Genet.
, vol.24
, pp. 1077-1091
-
-
Breda, C.1
-
17
-
-
84892456555
-
Enhanced ubiquitin-dependent degradation by Nedd4 protects against alpha-synuclein accumulation and toxicity in animal models of Parkinson's disease
-
17 Davies, S.E., et al. Enhanced ubiquitin-dependent degradation by Nedd4 protects against alpha-synuclein accumulation and toxicity in animal models of Parkinson's disease. Neurobiol. Dis. 64 (2014), 79–87.
-
(2014)
Neurobiol. Dis.
, vol.64
, pp. 79-87
-
-
Davies, S.E.1
-
18
-
-
84906503242
-
VPS35 dysfunction impairs lysosomal degradation of alpha-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease
-
18 Miura, E., et al. VPS35 dysfunction impairs lysosomal degradation of alpha-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease. Neurobiol. Dis. 71 (2014), 1–13.
-
(2014)
Neurobiol. Dis.
, vol.71
, pp. 1-13
-
-
Miura, E.1
-
19
-
-
84983539697
-
Glucocerebrosidase deficiency accelerates the accumulation of proteinase K-resistant alpha-synuclein and aggravates neurodegeneration in a Drosophila model of Parkinson's disease
-
19 Suzuki, M., et al. Glucocerebrosidase deficiency accelerates the accumulation of proteinase K-resistant alpha-synuclein and aggravates neurodegeneration in a Drosophila model of Parkinson's disease. Hum. Mol. Genet. 24 (2015), 6675–6686.
-
(2015)
Hum. Mol. Genet.
, vol.24
, pp. 6675-6686
-
-
Suzuki, M.1
-
20
-
-
84859169870
-
The mitochondrial chaperone protein TRAP1 mitigates alpha-Synuclein toxicity
-
20 Butler, E.K., et al. The mitochondrial chaperone protein TRAP1 mitigates alpha-Synuclein toxicity. PLoS Genet., 8, 2012, e1002488.
-
(2012)
PLoS Genet.
, vol.8
, pp. e1002488
-
-
Butler, E.K.1
-
21
-
-
84859708060
-
A novel “molecular tweezer” inhibitor of alpha-synuclein neurotoxicity in vitro and in vivo
-
21 Prabhudesai, S., et al. A novel “molecular tweezer” inhibitor of alpha-synuclein neurotoxicity in vitro and in vivo. Neurotherapeutics 9 (2012), 464–476.
-
(2012)
Neurotherapeutics
, vol.9
, pp. 464-476
-
-
Prabhudesai, S.1
-
22
-
-
84900434854
-
Axon degeneration and PGC-1alpha-mediated protection in a zebrafish model of alpha-synuclein toxicity
-
22 O'Donnell, K.C., et al. Axon degeneration and PGC-1alpha-mediated protection in a zebrafish model of alpha-synuclein toxicity. Dis. Model. Mech. 7 (2014), 571–582.
-
(2014)
Dis. Model. Mech.
, vol.7
, pp. 571-582
-
-
O'Donnell, K.C.1
-
23
-
-
84879838781
-
Axon degeneration in Parkinson's disease
-
23 Burke, R.E., O'Malley, K., Axon degeneration in Parkinson's disease. Exp. Neurol. 246 (2013), 72–83.
-
(2013)
Exp. Neurol.
, vol.246
, pp. 72-83
-
-
Burke, R.E.1
O'Malley, K.2
-
24
-
-
78149239653
-
Ammonium chloride and tunicamycin are novel toxins for dopaminergic neurons and induce Parkinson's disease-like phenotypes in medaka fish
-
24 Matsui, H., et al. Ammonium chloride and tunicamycin are novel toxins for dopaminergic neurons and induce Parkinson's disease-like phenotypes in medaka fish. J. Neurochem. 115 (2010), 1150–1160.
-
(2010)
J. Neurochem.
, vol.115
, pp. 1150-1160
-
-
Matsui, H.1
-
25
-
-
84930318487
-
Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein
-
25 Uemura, N., et al. Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein. PLoS Genet., 11, 2015, e1005065.
-
(2015)
PLoS Genet.
, vol.11
, pp. e1005065
-
-
Uemura, N.1
-
26
-
-
77956568458
-
Proteasome inhibition in medaka brain induces the features of Parkinson's disease
-
26 Matsui, H., et al. Proteasome inhibition in medaka brain induces the features of Parkinson's disease. J. Neurochem. 115 (2010), 178–187.
-
(2010)
J. Neurochem.
, vol.115
, pp. 178-187
-
-
Matsui, H.1
-
27
-
-
84969534214
-
Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death
-
27 Keatinge, M., et al. Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death. Hum. Mol. Genet. 24 (2015), 6640–6652.
-
(2015)
Hum. Mol. Genet.
, vol.24
, pp. 6640-6652
-
-
Keatinge, M.1
-
28
-
-
84886652249
-
Animal models of Parkinson's disease: vertebrate genetics
-
28 Lee, Y., et al. Animal models of Parkinson's disease: vertebrate genetics. Cold Spring Harb. Perspect. Med., 2, 2012, a009324.
-
(2012)
Cold Spring Harb. Perspect. Med.
, vol.2
, pp. a009324
-
-
Lee, Y.1
-
29
-
-
0036550101
-
Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system
-
29 Kirik, D., et al. Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J. Neurosci. 22 (2002), 2780–2791.
-
(2002)
J. Neurosci.
, vol.22
, pp. 2780-2791
-
-
Kirik, D.1
-
30
-
-
0345269757
-
Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease
-
30 Kirik, D., et al. Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 100 (2003), 2884–2889.
-
(2003)
Proc. Natl. Acad. Sci. U.S.A.
, vol.100
, pp. 2884-2889
-
-
Kirik, D.1
-
31
-
-
0036679197
-
alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease
-
31 Lo, B.C., et al. alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 99 (2002), 10813–10818.
-
(2002)
Proc. Natl. Acad. Sci. U.S.A.
, vol.99
, pp. 10813-10818
-
-
Lo, B.C.1
-
32
-
-
84856570373
-
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons
-
32 Decressac, M., et al. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons. Neurobiol. Dis. 45 (2012), 939–953.
-
(2012)
Neurobiol. Dis.
, vol.45
, pp. 939-953
-
-
Decressac, M.1
-
33
-
-
0242300619
-
alpha-Synuclein locus triplication causes Parkinson's disease
-
33 Singleton, A.B., et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science, 302, 2003, 841.
-
(2003)
Science
, vol.302
, pp. 841
-
-
Singleton, A.B.1
-
34
-
-
4644236043
-
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease
-
34 Ibanez, P., et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 364 (2004), 1169–1171.
-
(2004)
Lancet
, vol.364
, pp. 1169-1171
-
-
Ibanez, P.1
-
35
-
-
10744227740
-
Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications
-
35 Farrer, M., et al. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann. Neurol. 55 (2004), 174–179.
-
(2004)
Ann. Neurol.
, vol.55
, pp. 174-179
-
-
Farrer, M.1
-
36
-
-
2442700253
-
alpha-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication
-
36 Miller, D.W., et al. alpha-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology 62 (2004), 1835–1838.
-
(2004)
Neurology
, vol.62
, pp. 1835-1838
-
-
Miller, D.W.1
-
37
-
-
77952478217
-
Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes
-
37 Kuo, Y.M., et al. Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum. Mol. Genet. 19 (2010), 1633–1650.
-
(2010)
Hum. Mol. Genet.
, vol.19
, pp. 1633-1650
-
-
Kuo, Y.M.1
-
38
-
-
84878149242
-
A novel alpha-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of alpha-synuclein-GFP
-
38 Hansen, C., et al. A novel alpha-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of alpha-synuclein-GFP. Neurobiol. Dis. 56 (2013), 145–155.
-
(2013)
Neurobiol. Dis.
, vol.56
, pp. 145-155
-
-
Hansen, C.1
-
39
-
-
84885743813
-
Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model
-
39 Janezic, S., et al. Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), E4016–E4025.
-
(2013)
Proc. Natl. Acad. Sci. U.S.A.
, vol.110
, pp. E4016-E4025
-
-
Janezic, S.1
-
40
-
-
84886427013
-
Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P alpha-synuclein BAC transgenic mouse
-
40 Taylor, T.N., et al. Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P alpha-synuclein BAC transgenic mouse. Neurobiol. Dis. 62 (2014), 193–207.
-
(2014)
Neurobiol. Dis.
, vol.62
, pp. 193-207
-
-
Taylor, T.N.1
-
41
-
-
43249106066
-
Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein
-
41 Wang, L., et al. Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein. Neuroreport 19 (2008), 873–876.
-
(2008)
Neuroreport
, vol.19
, pp. 873-876
-
-
Wang, L.1
-
42
-
-
84861706581
-
alpha-Synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits
-
42 Hallett, P.J., et al. alpha-Synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits. Neurobiol. Dis. 47 (2012), 258–267.
-
(2012)
Neurobiol. Dis.
, vol.47
, pp. 258-267
-
-
Hallett, P.J.1
-
43
-
-
84863662763
-
Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system
-
43 Noorian, A.R., et al. Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system. Neurobiol. Dis. 48 (2012), 9–19.
-
(2012)
Neurobiol. Dis.
, vol.48
, pp. 9-19
-
-
Noorian, A.R.1
-
44
-
-
48249109112
-
Olfactory deficits in mice overexpressing human wildtype alpha-synuclein
-
44 Fleming, S.M., et al. Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. Eur. J. Neurosci. 28 (2008), 247–256.
-
(2008)
Eur. J. Neurosci.
, vol.28
, pp. 247-256
-
-
Fleming, S.M.1
-
45
-
-
78650723904
-
Inducible dopaminergic glutathione depletion in an alpha-synuclein transgenic mouse model results in age-related olfactory dysfunction
-
45 Kim, Y.H., et al. Inducible dopaminergic glutathione depletion in an alpha-synuclein transgenic mouse model results in age-related olfactory dysfunction. Neuroscience 172 (2011), 379–386.
-
(2011)
Neuroscience
, vol.172
, pp. 379-386
-
-
Kim, Y.H.1
-
46
-
-
84874335392
-
A progressive dopaminergic phenotype associated with neurotoxic conversion of alpha-synuclein in BAC-transgenic rats
-
46 Nuber, S., et al. A progressive dopaminergic phenotype associated with neurotoxic conversion of alpha-synuclein in BAC-transgenic rats. Brain 136 (2013), 412–432.
-
(2013)
Brain
, vol.136
, pp. 412-432
-
-
Nuber, S.1
-
47
-
-
84925875783
-
Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant alpha-synuclein
-
47 Zhang, S., et al. Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant alpha-synuclein. PLoS One, 10, 2015, e0119928.
-
(2015)
PLoS One
, vol.10
, pp. e0119928
-
-
Zhang, S.1
-
48
-
-
84880232532
-
Neuronal expression of familial Parkinson's disease A53T alpha-synuclein causes early motor impairment, reduced anxiety and potential sleep disturbances in mice
-
48 Rothman, S.M., et al. Neuronal expression of familial Parkinson's disease A53T alpha-synuclein causes early motor impairment, reduced anxiety and potential sleep disturbances in mice. J. Parkinsons Dis. 3 (2013), 215–229.
-
(2013)
J. Parkinsons Dis.
, vol.3
, pp. 215-229
-
-
Rothman, S.M.1
-
49
-
-
84937965847
-
Sleep dysfunction and EEG alterations in mice overexpressing alpha-synuclein
-
49 McDowell, K.A., et al. Sleep dysfunction and EEG alterations in mice overexpressing alpha-synuclein. J. Parkinsons Dis. 4 (2014), 531–539.
-
(2014)
J. Parkinsons Dis.
, vol.4
, pp. 531-539
-
-
McDowell, K.A.1
-
50
-
-
50549085408
-
Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration
-
50 Gao, H.M., et al. Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J. Neurosci. 28 (2008), 7687–7698.
-
(2008)
J. Neurosci.
, vol.28
, pp. 7687-7698
-
-
Gao, H.M.1
-
51
-
-
0034077041
-
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
-
51 Abeliovich, A., et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25 (2000), 239–252.
-
(2000)
Neuron
, vol.25
, pp. 239-252
-
-
Abeliovich, A.1
-
52
-
-
0035789203
-
Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice
-
52 Specht, C.G., Schoepfer, R., Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice. BMC Neurosci., 2, 2001, 11.
-
(2001)
BMC Neurosci.
, vol.2
, pp. 11
-
-
Specht, C.G.1
Schoepfer, R.2
-
53
-
-
0037109727
-
Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein
-
53 Cabin, D.E., et al. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J. Neurosci. 22 (2002), 8797–8807.
-
(2002)
J. Neurosci.
, vol.22
, pp. 8797-8807
-
-
Cabin, D.E.1
-
54
-
-
6944227811
-
Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions
-
54 Chandra, S., et al. Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 14966–14971.
-
(2004)
Proc. Natl. Acad. Sci. U.S.A.
, vol.101
, pp. 14966-14971
-
-
Chandra, S.1
-
55
-
-
40549093026
-
Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein
-
55 Senior, S.L., et al. Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein. Eur. J. Neurosci. 27 (2008), 947–957.
-
(2008)
Eur. J. Neurosci.
, vol.27
, pp. 947-957
-
-
Senior, S.L.1
-
56
-
-
78650431984
-
alphabetagamma-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction1
-
56 Greten-Harrison, B., et al. alphabetagamma-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction1. Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 19573–19578.
-
(2010)
Proc. Natl. Acad. Sci. U.S.A.
, vol.107
, pp. 19573-19578
-
-
Greten-Harrison, B.1
-
57
-
-
79956296370
-
Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family
-
57 Anwar, S., et al. Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family. J. Neurosci. 31 (2011), 7264–7274.
-
(2011)
J. Neurosci.
, vol.31
, pp. 7264-7274
-
-
Anwar, S.1
-
58
-
-
77957347060
-
Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro
-
58 Burre, J., et al. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329 (2010), 1663–1667.
-
(2010)
Science
, vol.329
, pp. 1663-1667
-
-
Burre, J.1
-
59
-
-
84875151201
-
alpha-Synuclein membrane association is regulated by the Rab3a recycling machinery and presynaptic activity
-
59 Chen, R.H., et al. alpha-Synuclein membrane association is regulated by the Rab3a recycling machinery and presynaptic activity. J. Biol. Chem. 288 (2013), 7438–7449.
-
(2013)
J. Biol. Chem.
, vol.288
, pp. 7438-7449
-
-
Chen, R.H.1
-
60
-
-
84935491802
-
alpha-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons
-
60 Zaltieri, M., et al. alpha-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons. J. Cell Sci. 128 (2015), 2231–2243.
-
(2015)
J. Cell Sci.
, vol.128
, pp. 2231-2243
-
-
Zaltieri, M.1
-
61
-
-
77957877526
-
Alpha-synuclein suppression by targeted small interfering RNA in the primate substantia nigra
-
61 McCormack, A.L., et al. Alpha-synuclein suppression by targeted small interfering RNA in the primate substantia nigra. PLoS One, 5, 2010, e12122.
-
(2010)
PLoS One
, vol.5
, pp. e12122
-
-
McCormack, A.L.1
-
62
-
-
77955176216
-
In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degeneration
-
62 Gorbatyuk, O.S., et al. In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degeneration. Mol. Ther. 18 (2010), 1450–1457.
-
(2010)
Mol. Ther.
, vol.18
, pp. 1450-1457
-
-
Gorbatyuk, O.S.1
-
63
-
-
84924536514
-
Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice
-
63 Cooper, J.M., et al. Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov. Disord. 29 (2014), 1476–1485.
-
(2014)
Mov. Disord.
, vol.29
, pp. 1476-1485
-
-
Cooper, J.M.1
-
64
-
-
84936818605
-
shRNA targeting alpha-synuclein prevents neurodegeneration in a Parkinson's disease model
-
64 Zharikov, A.D., et al. shRNA targeting alpha-synuclein prevents neurodegeneration in a Parkinson's disease model. J. Clin. Invest. 125 (2015), 2721–2735.
-
(2015)
J. Clin. Invest.
, vol.125
, pp. 2721-2735
-
-
Zharikov, A.D.1
-
65
-
-
84958037840
-
Is alpha-synuclein loss-of-function a contributor to Parkinsonian pathology? Evidence from non-human primates
-
65 Collier, T.J., et al. Is alpha-synuclein loss-of-function a contributor to Parkinsonian pathology? Evidence from non-human primates. Front. Neurosci., 10, 2016, 12.
-
(2016)
Front. Neurosci.
, vol.10
, pp. 12
-
-
Collier, T.J.1
-
66
-
-
79955757052
-
Passive immunization reduces behavioral and neuropathological deficits in an alpha–synuclein transgenic model of Lewy body disease
-
66 Masliah, E., et al. Passive immunization reduces behavioral and neuropathological deficits in an alpha–synuclein transgenic model of Lewy body disease. PLoS One, 6, 2011, e19338.
-
(2011)
PLoS One
, vol.6
, pp. e19338
-
-
Masliah, E.1
-
67
-
-
84866679781
-
Antibody-aided clearance of extracellular alpha-synuclein prevents cell-to-cell aggregate transmission
-
67 Bae, E.J., et al. Antibody-aided clearance of extracellular alpha-synuclein prevents cell-to-cell aggregate transmission. J. Neurosci. 32 (2012), 13454–13469.
-
(2012)
J. Neurosci.
, vol.32
, pp. 13454-13469
-
-
Bae, E.J.1
-
68
-
-
84902177925
-
Immunotherapy targeting alpha-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] alpha-synuclein mice
-
68 Lindstrom, V., et al. Immunotherapy targeting alpha-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] alpha-synuclein mice. Neurobiol. Dis. 69 (2014), 134–143.
-
(2014)
Neurobiol. Dis.
, vol.69
, pp. 134-143
-
-
Lindstrom, V.1
-
69
-
-
84903971406
-
Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models
-
69 Games, D., et al. Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models. J. Neurosci. 34 (2014), 9441–9454.
-
(2014)
J. Neurosci.
, vol.34
, pp. 9441-9454
-
-
Games, D.1
-
70
-
-
84901682081
-
Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials
-
70 Mandler, M., et al. Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials. Acta Neuropathol. 127 (2014), 861–879.
-
(2014)
Acta Neuropathol.
, vol.127
, pp. 861-879
-
-
Mandler, M.1
-
71
-
-
68449089023
-
Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein
-
71 Yu, W.H., et al. Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein. Am. J. Pathol. 175 (2009), 736–747.
-
(2009)
Am. J. Pathol.
, vol.175
, pp. 736-747
-
-
Yu, W.H.1
-
72
-
-
77949504405
-
Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy
-
72 Crews, L., et al. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS One, 5, 2010, e9313.
-
(2010)
PLoS One
, vol.5
, pp. e9313
-
-
Crews, L.1
-
73
-
-
70350550208
-
Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases
-
73 Spencer, B., et al. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. J. Neurosci. 29 (2009), 13578–13588.
-
(2009)
J. Neurosci.
, vol.29
, pp. 13578-13588
-
-
Spencer, B.1
-
74
-
-
84877351078
-
TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity
-
74 Decressac, M., et al. TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), E1817–E1826.
-
(2013)
Proc. Natl. Acad. Sci. U.S.A.
, vol.110
, pp. E1817-E1826
-
-
Decressac, M.1
-
75
-
-
84874487118
-
Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies
-
75 Sardi, S.P., et al. Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), 3537–3542.
-
(2013)
Proc. Natl. Acad. Sci. U.S.A.
, vol.110
, pp. 3537-3542
-
-
Sardi, S.P.1
-
76
-
-
84883688262
-
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
-
76 Jucker, M., Walker, L.C., Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501 (2013), 45–51.
-
(2013)
Nature
, vol.501
, pp. 45-51
-
-
Jucker, M.1
Walker, L.C.2
-
77
-
-
84893642253
-
Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases
-
77 Guo, J.L., Lee, V.M., Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat. Med. 20 (2014), 130–138.
-
(2014)
Nat. Med.
, vol.20
, pp. 130-138
-
-
Guo, J.L.1
Lee, V.M.2
-
78
-
-
69149089854
-
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein
-
78 Desplats, P., et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl. Acad. Sci. U.S.A. 106 (2009), 13010–13015.
-
(2009)
Proc. Natl. Acad. Sci. U.S.A.
, vol.106
, pp. 13010-13015
-
-
Desplats, P.1
-
79
-
-
84885470591
-
Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice
-
79 Rey, N.L., et al. Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathol. 126 (2013), 555–573.
-
(2013)
Acta Neuropathol.
, vol.126
, pp. 555-573
-
-
Rey, N.L.1
-
80
-
-
84962081972
-
A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration
-
80 Walsh, D.M., Selkoe, D.J., A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration. Nat. Rev. Neurosci. 17 (2016), 251–260.
-
(2016)
Nat. Rev. Neurosci.
, vol.17
, pp. 251-260
-
-
Walsh, D.M.1
Selkoe, D.J.2
-
81
-
-
84863433677
-
Prion-like acceleration of a synucleinopathy in a transgenic mouse model
-
81 Mougenot, A.L., et al. Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol. Aging 33 (2012), 2225–2228.
-
(2012)
Neurobiol. Aging
, vol.33
, pp. 2225-2228
-
-
Mougenot, A.L.1
-
82
-
-
84862609075
-
Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice
-
82 Luk, K.C., et al. Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J. Exp. Med. 209 (2012), 975–986.
-
(2012)
J. Exp. Med.
, vol.209
, pp. 975-986
-
-
Luk, K.C.1
-
83
-
-
84869109864
-
Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice
-
83 Luk, K.C., et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338 (2012), 949–953.
-
(2012)
Science
, vol.338
, pp. 949-953
-
-
Luk, K.C.1
-
84
-
-
84876057762
-
Prion-like spreading of pathological alpha-synuclein in brain
-
84 Masuda-Suzukake, M., et al. Prion-like spreading of pathological alpha-synuclein in brain. Brain 136 (2013), 1128–1138.
-
(2013)
Brain
, vol.136
, pp. 1128-1138
-
-
Masuda-Suzukake, M.1
-
85
-
-
84897977607
-
Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys
-
85 Recasens, A., et al. Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys. Ann. Neurol. 75 (2014), 351–362.
-
(2014)
Ann. Neurol.
, vol.75
, pp. 351-362
-
-
Recasens, A.1
-
86
-
-
84934955012
-
Intrastriatal injection of pre-formed mouse alpha-synuclein fibrils into rats triggers alpha-synuclein pathology and bilateral nigrostriatal degeneration
-
86 Paumier, K.L., et al. Intrastriatal injection of pre-formed mouse alpha-synuclein fibrils into rats triggers alpha-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiol. Dis. 82 (2015), 185–199.
-
(2015)
Neurobiol. Dis.
, vol.82
, pp. 185-199
-
-
Paumier, K.L.1
-
87
-
-
84934983329
-
alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration
-
87 Peelaerts, W., et al. alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522 (2015), 340–344.
-
(2015)
Nature
, vol.522
, pp. 340-344
-
-
Peelaerts, W.1
-
88
-
-
84907015989
-
Brain injection of alpha-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker
-
88 Sacino, A.N., et al. Brain injection of alpha-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker. J. Neurosci. 34 (2014), 12368–12378.
-
(2014)
J. Neurosci.
, vol.34
, pp. 12368-12378
-
-
Sacino, A.N.1
-
89
-
-
84947997820
-
Transmission of Soluble and Insoluble alpha-Synuclein to Mice
-
89 Jones, D.R., et al. Transmission of Soluble and Insoluble alpha-Synuclein to Mice. J. Neuropathol. Exp. Neurol. 74 (2015), 1158–1169.
-
(2015)
J. Neuropathol. Exp. Neurol.
, vol.74
, pp. 1158-1169
-
-
Jones, D.R.1
-
90
-
-
84888349390
-
Transmission of multiple system atrophy prions to transgenic mice
-
90 Watts, J.C., et al. Transmission of multiple system atrophy prions to transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), 19555–19560.
-
(2013)
Proc. Natl. Acad. Sci. U.S.A.
, vol.110
, pp. 19555-19560
-
-
Watts, J.C.1
-
91
-
-
84942860108
-
Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism
-
91 Prusiner, S.B., et al. Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), E5308–E5317.
-
(2015)
Proc. Natl. Acad. Sci. U.S.A.
, vol.112
, pp. E5308-E5317
-
-
Prusiner, S.B.1
-
92
-
-
84964853990
-
Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein
-
92 Bernis, M.E., et al. Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein. Acta Neuropathol. Commun., 3, 2015, 75.
-
(2015)
Acta Neuropathol. Commun.
, vol.3
, pp. 75
-
-
Bernis, M.E.1
-
93
-
-
84922092995
-
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
-
93 Holmqvist, S., et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 128 (2014), 805–820.
-
(2014)
Acta Neuropathol.
, vol.128
, pp. 805-820
-
-
Holmqvist, S.1
-
94
-
-
84904636970
-
Intramuscular injection of alpha-synuclein induces CNS alpha-synuclein pathology and a rapid-onset motor phenotype in transgenic mice
-
94 Sacino, A.N., et al. Intramuscular injection of alpha-synuclein induces CNS alpha-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 10732–10737.
-
(2014)
Proc. Natl. Acad. Sci. U.S.A.
, vol.111
, pp. 10732-10737
-
-
Sacino, A.N.1
-
95
-
-
84990041194
-
Neuroinvasion of alpha-synuclein prionoids after intraperitoneal and intraglossal inoculation
-
Published online August 3, 2016
-
95 Breid, S., et al. Neuroinvasion of alpha-synuclein prionoids after intraperitoneal and intraglossal inoculation. J. Virol., 2016 Published online August 3, 2016 http://dx.doi.org/10.1128/JVI.01399-16.
-
(2016)
J. Virol.
-
-
Breid, S.1
-
96
-
-
84903441419
-
Alpha-synuclein immunotherapy blocks uptake and templated propagation of misfolded alpha-synuclein and neurodegeneration
-
96 Tran, H.T., et al. Alpha-synuclein immunotherapy blocks uptake and templated propagation of misfolded alpha-synuclein and neurodegeneration. Cell Rep. 7 (2014), 2054–2065.
-
(2014)
Cell Rep.
, vol.7
, pp. 2054-2065
-
-
Tran, H.T.1
-
97
-
-
84939548666
-
Formaldehyde-fixed brain tissue from spontaneously ill alpha-synuclein transgenic mice induces fatal alpha-synucleinopathy in transgenic hosts
-
97 Schweighauser, M., et al. Formaldehyde-fixed brain tissue from spontaneously ill alpha-synuclein transgenic mice induces fatal alpha-synucleinopathy in transgenic hosts. Acta Neuropathol. 129 (2015), 157–159.
-
(2015)
Acta Neuropathol.
, vol.129
, pp. 157-159
-
-
Schweighauser, M.1
-
98
-
-
0036679197
-
alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease
-
98 Lo Bianco, C., et al. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 99 (2002), 10813–10818.
-
(2002)
Proc. Natl. Acad. Sci. U.S.A.
, vol.99
, pp. 10813-10818
-
-
Lo Bianco, C.1
-
99
-
-
63849332293
-
Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy
-
99 Chung, C.Y., et al. Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy. J. Neurosci. 29 (2009), 3365–3373.
-
(2009)
J. Neurosci.
, vol.29
, pp. 3365-3373
-
-
Chung, C.Y.1
-
100
-
-
33747441863
-
Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression
-
100 Maingay, M., et al. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression. Neurobiol. Dis. 23 (2006), 522–532.
-
(2006)
Neurobiol. Dis.
, vol.23
, pp. 522-532
-
-
Maingay, M.1
-
101
-
-
77958605778
-
Expression of human A53T alpha–synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's disease
-
101 Koprich, J., et al. Expression of human A53T alpha–synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's disease. Mol. Neurodegener., 5, 2010, 43.
-
(2010)
Mol. Neurodegener.
, vol.5
, pp. 43
-
-
Koprich, J.1
-
102
-
-
79952321038
-
Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synuclein
-
102 Koprich, J.B., et al. Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synuclein. PLoS One, 6, 2011, e17698.
-
(2011)
PLoS One
, vol.6
, pp. e17698
-
-
Koprich, J.B.1
-
103
-
-
84896694412
-
Morphological and behavioral impact of AAV2/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system
-
103 Gombash, S.E., et al. Morphological and behavioral impact of AAV2/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system. PLoS One, 8, 2013, e81426.
-
(2013)
PLoS One
, vol.8
, pp. e81426
-
-
Gombash, S.E.1
-
104
-
-
84904400256
-
Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneurons
-
104 Aldrin-Kirk, P., et al. Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneurons. PLoS One, 9, 2014, e100869.
-
(2014)
PLoS One
, vol.9
, pp. e100869
-
-
Aldrin-Kirk, P.1
-
105
-
-
84923396817
-
Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral vectors
-
105 Van der Perren, A., et al. Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral vectors. Neurobiol. Aging 36 (2015), 1543–1558.
-
(2015)
Neurobiol. Aging
, vol.36
, pp. 1543-1558
-
-
Van der Perren, A.1
-
106
-
-
85005846700
-
Direct detection of alpha synuclein oligomers in vivo
-
106 Dimant, H., et al. Direct detection of alpha synuclein oligomers in vivo. Acta Neuropathol. Commun., 1, 2013, 6.
-
(2013)
Acta Neuropathol. Commun.
, vol.1
, pp. 6
-
-
Dimant, H.1
-
107
-
-
84908384520
-
Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not alpha-synuclein–induced neuronal cell loss
-
107 McFarland, N.R., et al. Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not alpha-synuclein–induced neuronal cell loss. PLoS One, 9, 2014, e86048.
-
(2014)
PLoS One
, vol.9
, pp. e86048
-
-
McFarland, N.R.1
-
108
-
-
84922758351
-
Anti-human alpha-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-alpha–synuclein rat model of Parkinson's disease
-
108 Shahaduzzaman, M., et al. Anti-human alpha-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-alpha–synuclein rat model of Parkinson's disease. PLoS One, 10, 2015, e0116841.
-
(2015)
PLoS One
, vol.10
, pp. e0116841
-
-
Shahaduzzaman, M.1
-
109
-
-
84929448327
-
Treatment with trehalose prevents behavioral and neurochemical deficits produced in an AAV alpha-synuclein rat model of Parkinson's disease
-
109 He, Q., et al. Treatment with trehalose prevents behavioral and neurochemical deficits produced in an AAV alpha-synuclein rat model of Parkinson's disease. Mol Neurobiol. 53 (2015), 2258–2268.
-
(2015)
Mol Neurobiol.
, vol.53
, pp. 2258-2268
-
-
He, Q.1
-
110
-
-
84965046341
-
Inhibition of the JAK/STAT pathway protects against alpha-synuclein-induced neuroinflammation and dopaminergic neurodegeneration
-
110 Qin, H., et al. Inhibition of the JAK/STAT pathway protects against alpha-synuclein-induced neuroinflammation and dopaminergic neurodegeneration. J. Neurosci. 36 (2016), 5144–5159.
-
(2016)
J. Neurosci.
, vol.36
, pp. 5144-5159
-
-
Qin, H.1
-
111
-
-
84947037583
-
Glucocerebrosidase gene therapy prevents alpha-synucleinopathy of midbrain dopamine neurons
-
111 Rocha, E.M., et al. Glucocerebrosidase gene therapy prevents alpha-synucleinopathy of midbrain dopamine neurons. Neurobiol. Dis. 82 (2015), 495–503.
-
(2015)
Neurobiol. Dis.
, vol.82
, pp. 495-503
-
-
Rocha, E.M.1
-
112
-
-
84923491254
-
FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an alpha-synuclein-based rat model for Parkinson's disease
-
112 Van der Perren, A., et al. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an alpha-synuclein-based rat model for Parkinson's disease. Neurobiol. Aging 36 (2015), 1559–1568.
-
(2015)
Neurobiol. Aging
, vol.36
, pp. 1559-1568
-
-
Van der Perren, A.1
-
113
-
-
33947127695
-
Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain
-
113 Eslamboli, A., et al. Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain. Brain 130 (2007), 799–815.
-
(2007)
Brain
, vol.130
, pp. 799-815
-
-
Eslamboli, A.1
-
114
-
-
84994834254
-
Late-Breaking Abstracts, A non-human primate model of Parkinson's disease based on viral vector mediated overexpression of alpha-synuclein
-
LBA 11
-
114 Koprich, J.B., et al. Late-Breaking Abstracts, A non-human primate model of Parkinson's disease based on viral vector mediated overexpression of alpha-synuclein. 19th International Congress of Parkinson's Disease and Movement Disorders (editors), 2015 LBA 11.
-
(2015)
19th International Congress of Parkinson's Disease and Movement Disorders (editors)
-
-
Koprich, J.B.1
-
115
-
-
84921033215
-
Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease
-
115 Kalia, L.V., et al. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol. 72 (2015), 100–105.
-
(2015)
JAMA Neurol.
, vol.72
, pp. 100-105
-
-
Kalia, L.V.1
-
116
-
-
84923207477
-
Role of alpha-synuclein in inducing innate and adaptive immunity in Parkinson disease
-
116 Allen Reish, H.E., Standaert, D.G., Role of alpha-synuclein in inducing innate and adaptive immunity in Parkinson disease. J. Parkinsons Dis. 5 (2015), 1–19.
-
(2015)
J. Parkinsons Dis.
, vol.5
, pp. 1-19
-
-
Allen Reish, H.E.1
Standaert, D.G.2
-
117
-
-
84939145610
-
Leucine-rich repeat kinase 2 (LRRK2) pharmacological inhibition abates alpha-synuclein gene-induced neurodegeneration
-
117 Daher, J.P., et al. Leucine-rich repeat kinase 2 (LRRK2) pharmacological inhibition abates alpha-synuclein gene-induced neurodegeneration. J. Biol. Chem. 290 (2015), 19433–19444.
-
(2015)
J. Biol. Chem.
, vol.290
, pp. 19433-19444
-
-
Daher, J.P.1
|